Literature DB >> 7769726

Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins.

E Paine1, R I Scheinman, A S Baldwin, N Raab-Traub.   

Abstract

This study demonstrates that the Epstein-Barr virus protein LMP1 activates a specific subset of NF-kappa B/Rel proteins in the C33 epithelial cell line. Western immunoblot analysis used to analyze the intracellular distribution and abundance of the proteins present in these complexes demonstrated that levels of the p50 and p52 proteins were significantly elevated in the nuclei of LMP1-expressing cells. The data also suggest that LMP1 facilitates the translocation of p50 to the nucleus and may affect the processing of the p100 and p105 precursor proteins or the stability of p52 and p50.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769726      PMCID: PMC189208          DOI: 10.1128/JVI.69.7.4572-4576.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

2.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 3.  Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system.

Authors:  H C Liou; D Baltimore
Journal:  Curr Opin Cell Biol       Date:  1993-06       Impact factor: 8.382

4.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Authors:  A A Beg; T S Finco; P V Nantermet; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 5.  Epstein-Barr virus and nasopharyngeal carcinoma.

Authors:  N Raab-Traub
Journal:  Semin Cancer Biol       Date:  1992-10       Impact factor: 15.707

6.  Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation.

Authors:  T Lernbecher; U Müller; T Wirth
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

7.  Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.

Authors:  K Brown; S Park; T Kanno; G Franzoso; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.

Authors:  M L Scott; T Fujita; H C Liou; G P Nolan; D Baltimore
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

9.  NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.

Authors:  R I Scheinman; A A Beg; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

10.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

View more
  44 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.

Authors:  Jianmin Zuo; Laura L Quinn; Jennifer Tamblyn; Wendy A Thomas; Regina Feederle; Henri-Jacques Delecluse; Andrew D Hislop; Martin Rowe
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  LMP1 strain variants: biological and molecular properties.

Authors:  Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Virus and cell RNAs expressed during Epstein-Barr virus replication.

Authors:  Jing Yuan; Ellen Cahir-McFarland; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Unique signaling properties of CTAR1 in LMP1-mediated transformation.

Authors:  Bernardo A Mainou; David N Everly; Nancy Raab-Traub
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

6.  Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.

Authors:  Pegah Johansson; Ann Jansson; Ulla Rüetschi; Lars Rymo
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

7.  The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

8.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

9.  Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta.

Authors:  Che-Pei Kung; David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

10.  Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.

Authors:  Do Nguyen-Van; Ingemar Ernberg; Ingemar Enrberg; Phi Phan-Thi Phi; Chinh Tran-Thi; LiFu Hu
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.